What is the GBM Drug Bank?
The GBM Drug Bank is a drug discovery and informatics resource collating information about drugs and exploratory compounds that have potential as treatments for GBM. All entries are manually curated.
Who created the GBM Drug Bank?
The GBM Drug Bank was created and is maintained by IOTA Pharmaceuticals based in Cambridge (UK). The GBM Drug Bank was created as part of the WINDOW Consortium and funded by the Brain Tumour Charity (UK) (grant number GN-000429).
Although we strive to make sure that all the information on this webpage is correct, IOTA Pharmaceuticals cannot guarantee the validity of any information in the GBM Drug Bank. We accept no liability for any damages resulting from the use of this database. The GBM Drug Bank is meant as a resource for preclinical research and is not suitable as a guideline for the treatment of patients.